Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.20 -0.13 (-3.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Camp4 Therapeutics (CAMP) EPS (Basic) (2023 - 2026)

Updated

Camp4 Therapeutics (CAMP) recorded EPS (Basic) of -$0.58 in Q2 2026, compared with -$0.62 a year earlier.

Analysis

Camp4 Therapeutics (CAMP) EPS (Basic) (2023 - 2026) Analysis & Trends

On a TTM basis, Camp4 Therapeutics' EPS (Basic) came in at -$1.85 as of Jun 30, 2026; for FY2025, it was -$2.65.

  • Across earlier years, EPS (Basic) came in at -$11.04 in FY2024 and -$124.79 in FY2023.
  • Quarterly EPS (Basic) has ranged from -$32.89 in Q4 2023 to -$0.32 in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$0.32 (Q1 2026), -$1.33 (Q4 2025) and -$0.55 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.23
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.05
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.01
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.14
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.96
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.57
10 Camp4 Therapeutics 341.83 Mn -77.81 Mn - -0.37
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -0.37
Jun 30, 2026 -0.58
Mar 31, 2026 -0.32
Dec 31, 2025 -1.33
Sep 30, 2025 -0.55
Jun 30, 2025 -0.62
Mar 31, 2025 -0.62
Dec 31, 2024 -2.83
Sep 30, 2024 -24.19
Jun 30, 2024 -26.00
Mar 31, 2024 -26.57
Dec 31, 2023 -32.89
Sep 30, 2023 -29.21
API Access

Camp4 Therapeutics EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=CAMP&period=max&api_key=YOUR_API_KEY